NEIL E. FLESHNER - 29 Mar 2022 Form 4 Insider Report for POINT Biopharma Global Inc.

Role
Chief Medical Officer, Director
Signature
/s/ William L. Demers, by Power of Attorney for Neil E. Fleshner
Issuer symbol
N/A
Transactions as of
29 Mar 2022
Net transactions value
$0
Form type
4
Filing time
31 Mar 2022, 16:57:24 UTC
Previous filing
08 Jul 2021
Next filing
26 May 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PNT Stock Option (Right to Buy) Award $0 +60,234 $0.000000 60,234 29 Mar 2022 Common Stock 60,234 $8.13 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests 25% on the first anniversary of the date of grant with the remaining 75% vesting in three equal annual installments thereafter.